Archive 1995–2023

Introduction. Due to the current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is necessary to take therapeutic decisions concerning the simultaneous use of psychopharmacology and drugs supporting the elimination of the virus, especially chloroquine.

Case study. A 36-year-old female patient, with a diagnosis of paranoid schizophrenia, treated with clozapine, zuclopenthixol and lamotrigine, was diagnosed with SARS-CoV-2 infection. Following the recommendations of a specialist of infectious diseases, azithromycin and chloroquine were introduced to the treatment. Due to potential drug interactions, morphology, AST, ALT and ECG were monitored. No abnormalities of monitored parameters were observed. The virus was effectively eliminated.

Comments. With appropriate patient monitoring and care, antipsychotics were successfully combined with chloroquine and azithromycin in short-term therapy of lung inflammatory changes associated with SARS-CoV-2 infection.